Pantoprazole Sodium

: http://unibromcorp.com

This product has been discontinued and removed from our shelves.

Identification

Product name	Pantoprazole sodium
Other names	Pantoprozole soclium Ph.Eur, pantoprozole sodium, sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide, 5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-yl]sodium, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl) sulfinyl)-1H-benzimidazole sodium
CAS No.	138786-67-1
Molecular formula	C₁₆H₁₄F₂N₃NaO₄S
Molecular weight	405.3516
Chemical structure
Uses	1. Pantoprazole sodium specifically acts on the parietal cells of gastric mucosa to inhibit the hydrogen-potassium adenosinetriphosphatase (H,K-ATPase) enzyme system, thereby suppressing gastric acid secretion. 2. Compared with omeprazole and lansoprazole, this pharmaceutical ingredient exhibits weaker inhibiting effect on cytochrome P450 system. 3. Our product is mainly utilized to treat gastric acid related diseases including peptic ulcer disease and Zollinger- Ellison syndrome, and it is extremely suitable for emesis, aphagosis, bleeding ulcer, intractable ulcer as well as acute pancreatitis. In addition, it could prevent stress ulcer caused by major surgery or serious wound.

Technical Data

Item	Specification
Standard	CP2005
Appearance	White or off white crystalline powder
Assay (%)	98.0-102.0
Methylbenzene (%)	≤0.089
Acetone (%)	≤0.5
Water (%)	4.0-6.0
Heavy metal (ppm)	≤20

Note: The technical parameters are subject to change without prior notice.

Packing
Pantoprazole sodium is packed in 25kg drum or paperboard carton.